Investor Relations

Contact Us

Corporate Contact Investor Relations Human Resources General Inquiries

INFOGRAPHIC
Healthcare in 2025
OPEN
VIDEO
Explore our Video Hub
Visit Hub
Video Portal
video/mp4
NGS
The dawn of a new age
Read story
MICROBIOME RESEARCH
Behavior - it's all in our gut
Read Interview
TUBERCULOSIS
"Our goal is to develop easy and quick tests"
Read Interview

Latest press releases

SUBSCRIBE TO RSS-FEED

06.12.2018
QIAGEN announces new collaboration to develop companion diagnostic to guide treatment for patients with PIK3CA-mutated advanced breast cancer
READ MORE
30.11.2018
QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs
READ MORE
29.11.2018
QIAGEN launches QCI Interpret bioinformatics features for use for blood cancers as well as a novel myeloid gene panel for GeneReader NGS System
READ MORE
28.11.2018
QIAGEN extends comprehensive offering for cervical cancer screening with European launch of QIAscreen HPV PCR Test
READ MORE
27.11.2018
QIAGEN releases new CLC Genomics Workbench solution designed for use in significantly more customer segments
READ MORE
07.11.2018
QIAGEN N.V. announces successful completion of non-U.S. offer involving convertible notes
READ MORE
06.11.2018
Ad-hoc announcement pursuant to Art. 17 MAR
READ MORE
06.11.2018
QIAGEN N.V. launches non-US offering of cash settled convertible notes combined with convertible note hedge and warrant transactions
READ MORE
06.11.2018
QIAGEN N.V. announces terms of new convertible notes
READ MORE
05.11.2018
QIAGEN launches new DNeasy Plant Pro Kit
READ MORE

SEE ALL RELEASES

At a glance

Key figures teaser

Key figures

Strategy teaser

Strategy

IR - Share data teaser

Share data

Shareholder structure

Corporate calendar

SEE ALL EVENTS

Financial reports

SEE ALL REPORTS

Our social media channels

Visit our Social Hub

Do you have further questions?

FOLLOW US ON SOCIAL MEDIA

LANGUAGE

OTHER WEBSITES

© QIAGEN 2013 - 18. All rights reserved